Climb Bio Inc (CLYM) — Long-term Investment Intensity
Climb Bio Inc (CLYM) has a Long-term Investment Intensity of 35.5% as of December 2025. Long-term investments of $59.57 Million represent 35.5% of total assets of $167.74 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See net assets of Climb Bio Inc for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Climb Bio Inc Long-term Investment Intensity (2021–2025)
This chart shows how Climb Bio Inc's Long-term Investment Intensity has evolved across 3 annual periods from 2021 to 2025. As of December 2025, the intensity stands at 35.5%, reflecting long-term investments of $59.57 Million against total assets of $167.74 Million USD. Also explore CLYM asset base for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Climb Bio Inc (2021–2025)
The table below presents the year-by-year Long-term Investment Intensity for Climb Bio Inc from 2021 to 2025, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see CLYM market cap.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 35.5% | $59.57 Million | $167.74 Million | ▲ +7.1 pp |
| 2024 | 28.4% | $61.61 Million | $217.19 Million | ▲ +14.0 pp |
| 2021 | 14.4% | $24.92 Million | $173.24 Million | — |